China Traditional Chinese Medicine Holdings Co. Limited's high P/E ratio is justified by its superior earnings outlook. A significant drop in share price in the near future is unlikely due to the low potential for earnings deterioration.
China Traditional Chinese Medicine Holdings' share price reflects changes in EPS. The company's performance has worsened over the past year compared to the past five years, suggesting a need for significant improvement in fundamentals.
中国中薬に関するコメント
HKD772.9M Southbound Trading Net Inflow to CNOOC
There was HKD753 million and HKD78 million Southbound Trading net outflow from $中国中薬(00570.HK)$ and $中芯国際(00981.HK)$ .
For $SH->HK コネクト(GangGuTong.HK)$ , $中国海洋石油(00883.HK)$ was the most active stock with highest net inflow of HKD500.7 mill...
As for financials, $HSBC(00005.HK)$ opened flat at $57.95. $香港証券取引所(00388.HK)$ lost 0.5% at $231.4. $友邦保険(01299.HK)$ shed 1.6% at $58.65. Chinese prope...
South bound capital sold China Mobile net of HK $433 million and bought Tencent net of HK $503 million
$中国移動(00941.HK)$, $新東方在線(01797.HK)$ and $中国中薬(00570.HK)$ were sold net of HK $433 million, HK $230 million and HK $131 million respectively;
$テンセント(00700.HK)$ , $XPENG-W(09868.HK)$ , $KUAISHOU-W(01024.HK)$ and $美団点評(03690.HK)$ were net buyers of HK $503 million, HK $289 million...
DBS: China Traditional Chinese Medicine Holdings Co – Hold Target Price HK$4.50
$中国中薬(00570.HK)$
まだコメントはありません